Revision history

Continuous renal replacement therapy (CRRT): Consider delayed administration of concurrent echinocandins, such as caspofungin, to reduce the risk of adsorption onto new polyacrylonitrile (PAN)-based filter membranes DSI/2026/014 — 1 version recorded. Nothing here has been overwritten.

  1. Version 1 original current
    Continuous renal replacement therapy (CRRT): Consider delayed administration of concurrent echinocandins, such as caspofungin, to reduce the risk of adsorption onto new polyacrylonitrile (PAN)-based filter membranes DSI/2026/014

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.